openPR Logo
Press release

Agoraphobia Market Analysis By therapy, drug treatment, Highlights & Synopsis, Global Foresight to 2023

10-30-2017 06:10 PM CET | Health & Medicine

Press release from: Market Research Future

Agoraphobia Market Analysis By therapy, drug treatment,

Agoraphobia is the fear of places or situations that causes panic behaviour with a feeling of being trapped or helpless. The situation may be actual or anticipated such as using public transportation, being in open or enclosed spaces or being in a crowded place. Signs and symptoms of a panic attack in agoraphobia are rapid heart rate, trouble breathing, chest pain, dizziness, excessive sweating, feeling of loss of control and fear of dying etc. Agoraphobia is primarily caused by a combination of genetic and environmental factors. Other conditions include separation anxiety, posttraumatic stress and depression. Agoraphobia patients are at a higher risk of depression and substance use disorder. Agoraphobia is prevalent in about 1.7% of adults with women having a greater propensity to be affected by the disorder.
The market for agoraphobia diagnosis and treatment is driven by factors such as growing prevalence of stress, genetic predisposition, sedentary lifestyles, deteriorating health standards in the contemporary lifestyles, substance abuse, lack of intimacy in relations, increasing awareness and screening etc. The market restraints are social stigma regarding psychotherapy, low focus and penetration of mental health in society, tendency to hide mental disorders and reluctance to therapy and treatment etc.
Considering all these factors, the market for agoraphobia diagnosis and treatment is expected to reach $ 800 million by the end of 2023, this market is projected to growing at a CAGR of ~ 4.3 % during 2017-2023.
Get a Copy of Sample Report @ https://www.marketresearchfuture.com/sample_request/4007
Cognitive behavioural therapy is the leading psychotherapy for agoraphobia. Cognitive behavioural therapy focuses on teaching skills to better tolerate anxiety, challenging your worries and anticipating most probable and realistic effects of the situation or place. Exposure therapy focus on increasing exposure to places which trigger a panic attack and to cope and tolerate symptoms of agoraphobia. Desensitization caused by exposure therapy results in habituation which improves the condition.
The therapist helps the patient to understand thought patterns and false beliefs or attitudes which raises anxiety with an aim to change ways of thinking and to make thought patterns more realistic and helpful. Selective serotonin reuptake inhibitors such as fluoxetine and sertraline are the standard drug therapy for the treatment of panic disorder in agoraphobia. Anti-anxiety drugs called benzodiazepines are used as or to relieve acute anxiety as they are habit-forming. Dietary supplements and alternative medicines such as kava kava have been tried and have found to be useful. However, kava kava has been reports of serious liver damage. The Food and Drug Administration has issued warnings and thus kava kava should be avoided if liver problems exists.
Key players of Global Agoraphobia market:
• Eli Lilly & Co.
• Bristol-Myers Squibb
• AstraZeneca
• Pfizer inc
• GlaxoSmithKline plc
• Johnson & Johnson
• Sandoz Inc.
• Apotex Corp.
• Mylan Pharmaceuticals Inc.
Segments:
The global agoraphobia market is segmented on the basis of drug treatment, therapy and end users. Based on drug treatment, the market has been segmented as selective serotonin reuptake inhibitors, norepinephrine reuptake inhibitors, tricyclic antidepressants, anti-anxiety medications and others. Based on the therapy, the market has been segmented as psychotherapy, cognitive behavioral therapy (CBT), exposure therapy and others. Based on the end users, the market has been segmented as hospitals, clinics, academics and others.
Browse Full Report Details @ https://www.marketresearchfuture.com/reports/agoraphobia-market-4007
Regional analysis
US accounts for the maximum market share due to favorable insurance penetration, excellent reimbursement scenario and greater expenditure on healthcare. The faster market uptake of new technology and devices in the US is also an important driver of the market for global agoraphobia diagnosis and treatment. Europe is the second largest market due to large disposable income and rising awareness. Asia Pacific region is expected to have the most future potential and it is estimated to be led by China and India. The Middle East & Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The regions of Africa are expected to witness a moderate growth due to poor economic and political conditions and poor healthcare penetration.
The report for Global Agoraphobia market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The report also gives a broad study of the different market segments and regions.
Continue…
We are thankful for the support and assistance from Agoraphobia Market Research Report- Global Forecast till 2023 related technical experts and marketing experts during Research Team survey and interviews.

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Media Contact:
Akash Anand,
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
+1 646 845 9312
Email: akash.anand@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Agoraphobia Market Analysis By therapy, drug treatment, Highlights & Synopsis, Global Foresight to 2023 here

News-ID: 793711 • Views: 254

More Releases from Market Research Future

Semiconductor IC Tester Market Growth Factor, Demand, Size, Share, Trends, Growt …
The Semiconductor IC Tester Market research report includes Market segmentation and overlays shadow upon the leading market players highlighting the favourable competitive landscape and trends prevailing over the years. This study provides information about the sales and revenue during the historic and forecasted period of 2019 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the Semiconductor IC Tester market growth. Semiconductor IC Tester is
Tilt Sensor Market Share, COVID-19 Pandemic Impact, Comprehensive Analysis, Oppo …
Global Tilt Sensor Market Highlights: The global Tilt Sensor Market is growing rapidly over 7.42% of CAGR and is expected to reach at USD 257.64 million by the end of forecast period. The global tilt sensor market has been witnessing a steady growth over the last few years on account of rapid growth of automobile and transportation market, high implementation of sensors in the constructions machines and rising demand for tilt
High Altitude Long Endurance Market Demand, Growth, COVID-19 Pandemic Impact, Ap …
High Altitude Long Endurance (Pseudo Satellite) Market Overview Market Research Future (MRFR) anticipates that the High Altitude Long Endurance Market 2020 could potentially achieve a strong valuation of USD 23 billion by 2022. The market is also projected to advance at an approximate rate of 9% between 2016 and 2022 (review period). We will provide covid-19 impact analysis with the report. The research on COVID-19 impact offers an in-depth analysis post
Function as a Service Market by Top Manufacturers, COVID-19 Pandemic Impact, App …
Market Highlights Function as a Service (FaaS) is the concept of serverless computing via serverless architectures. Software developers can leverage this to deploy an individual “function”, action, or piece of business logic. The serverless architecture has many benefits as, it reduces time to market, lowers the operational costs, reduces the complexity of software and others. Therefore, the demand for serverless architecture is driving the function as a service market. The factors driving

All 5 Releases


More Releases for Agoraphobia

Agoraphobia Market 2018: Impact of Drivers, Market Challenges and Forecast Until …
Global Agoraphobia Market Insights, Forecast to 2025 Industry Research Report is an exhaustive study on the present market scenario of the global Agoraphobia industry with a special focus on the Agoraphobia market of this industry. Download PDF Brochure of Agoraphobia Market spread across 111 Pages, Profiling Companies and supported with tables and figures are now available at https://www.reportsnreports.com/contacts/requestsample.aspx?name=1705243 Agoraphobia (ag-uh-ruh-FOE-be-uh) is a type of anxiety disorder in which you fear
Agoraphobia Market Comprehensive Analysis & is To Hit USD ~ 800 Million By 2023, …
Agoraphobia market Study By drug treatment, therapy, Industry & is expected to reach $ 800 million by the end of 2023, this market is projected to growing at a CAGR of ~ 4.3 % during 2017-2023 Market Synopsis of Global Agoraphobia market: Market scenario: Global Agoraphobia market is expected to reach $ 800 million by the end of 2023, this market is projected to growing at a CAGR of ~ 4.3 % during
Agoraphobia Market Complete Study & Global Foresight to 2023
Agoraphobia market Analysis: By Key Companies- (Eli Lilly & Co. Bristol-Myers Squibb AstraZeneca Pfizer inc ), by drug treatment (selective serotonin reuptake inhibitors, norepinephrine reuptake inhibitors, others) by therapy (Psychotherapy, Cognitive Behavioral Therapy (CBT), others) by end users - Global Forecast till 2023 Market Synopsis of Global Agoraphobia market: Market scenario: Agoraphobia is the fear of places or situations that causes panic behaviour with a feeling of being trapped or helpless.
Agoraphobia Market: Magnificent Exploration 800 Million, At CAGR of 4.3% By 2023
Market Research Future published a research report on “Fetal Macrosomia Market Research Report - Global Forecast till 2023”- Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2023. Agoraphobia market information: by drug treatment (selective serotonin reuptake inhibitors, norepinephrine reuptake inhibitors, others) by therapy (Psychotherapy, Cognitive Behavioral Therapy (CBT), others) by end users - Global Forecast till 2023 Market Synopsis of Global Agoraphobia market: Market scenario: Agoraphobia is the fear of places
Global Agoraphobia Clinical Trials Assessment and Review ,H1, 2017 | Medical Ind …
Market Research Hub's clinical trial report, Global Agoraphobia Assessment and Clinical Trials Review, H1, 2017" provides an overview of Agoraphobia clinical trials scenario. This report provides top line data relating to the clinical trials on Agoraphobia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial
Global Research details developments in the Agoraphobia Clinical Trials Review, …
The report analyzes and presents an overview of " Agoraphobia Global Clinical Trials Review, H2, 2016 " worldwide. GlobalData's clinical trial report, Agoraphobia Global Clinical Trials Review, H2, 2016" provides an overview of Agoraphobia clinical trials scenario. This report provides top line data relating to the clinical trials on Agoraphobia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers